saw bioniche ad ~ 13:15 on BNNand that to:
Takeda Pharmaceutical Co.’s best- selling drug, Actos for diabetes, will be pulled from the French market after a study showed it carried a slightly increased risk of bladder cancer, the country’s drug regulator said.
Patients taking the treatment shouldn’t stop without consulting their physician, the regulator, known as Afssaps, said in a statement on its website. Doctors should no longer prescribe the drug, the agency said after holding a meeting today to consider the medicine’s risks and benefits.
Actos, also known as pioglitazone, had sales of 387.9 billion yen ($4.8 billion) in the last fiscal year, accounting for 27 percent of Osaka, Japan-based Takeda’s revenue. The drug was approved in Europe in 2000 as an option for patients who didn’t benefit from metformin, a standard treatment, or for those also taking metformin or insulin. About 230,000 patients in France use Actos, Afssaps said.
https://www.bloomberg.com/news/2011-06-09/takeda-s-actos-drug-suspended-in-france-on-cancer-risk-study-3-.html